Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 28, 2014; 20(20): 6226-6235
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6226
Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection
Semra Tunçbilek
Semra Tunçbilek, Department of Infectious Diseases and Clinical Microbiology, Ufuk University School of Medicine, 06520 Ankara, Turkey
Author contributions: Tunçbilek S reviewed all the manuscripts listed in references section and wrote this review.
Correspondence to: Semra Tunçbilek, Professor, Department of Infectious Diseases and Clinical Microbiology, Ufuk University School of Medicine, Mevlana Bulvarı (Konya Yolu) No. 86-88, Balgat, 06520 Ankara, Turkey. semrakuli@yahoo.com
Telephone: +90-312-2044149 Fax:+90-312-2872390
Received: October 9, 2013
Revised: December 9, 2013
Accepted: January 2, 2014
Published online: May 28, 2014
Abstract

Hepatitis B virus (HBV) infection is still a public health problem worldwide, being endemic in some parts of the world. It can lead to serious liver diseases such as chronic hepatitis, cirrhosis, and hepatocellular cancer. The differences in host immune response can be one of the reasons for the various clinical presentations of HBV infection. Polymorphisms of genes encoding the proinflammatory and antiinflammatory cytokines, which are responsible for regulation of the immune response, can affect the clinical presentation of the infection. Particularly, the polymorphisms of the genes encoding cytokines such as interleukin (IL)-1, IL-6, IL-8, IL-10, IL-18, IL-28B, interferon-γ, tumor necrosis factor-α, tumor growth factor-β1, and regulatory molecules like vitamin D receptor and chemokine receptor 5 can be responsible for different clinical presentations of HBV infections. The genomic information about cytokines and other mediators can be important for determining high-risk people for developing chronic hepatitis or hepatocellular cancer and may be used to plan treatment and preventive approaches for these people. In this review, the current knowledge in the literature on the association between cytokine/regulatory molecule gene polymorphisms and clinical course of chronic HBV infection is summarized, and the clinical implementations and future prospects regarding this knowledge are discussed.

Keywords: Hepatitis B virus, Cytokine, Polymorphism, Chronic hepatitis

Core tip: The specific polymorphisms of genes encoding cytokines, such as interleukin (IL)-1, IL-8, IL-10, IL-18, IL-28B, tumor necrosis factor-α, interferon-γ, tumor growth factor-β1, and regulatory molecules such as vitamin D receptor and chemokine receptor 5 affect the clinical course of chronic hepatitis B virus (HBV) infection. This review aims to summarize the literature on cytokine gene polymorphisms and chronic HBV infection and discuss future prospects regarding the clinical implication of these polymorphisms.